These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 31599024

  • 1. Dermatomycoses in the Israeli defense forces-Epidemiological and clinical aspects.
    Ravid A, Michael F, Daniel C, Esther S.
    Mycoses; 2020 Jan; 63(1):65-70. PubMed ID: 31599024
    [Abstract] [Full Text] [Related]

  • 2. Tinea capitis dermatophytes: susceptibility to antifungal drugs tested in vitro and in vivo.
    Mock M, Monod M, Baudraz-Rosselet F, Panizzon RG.
    Dermatology; 1998 Jan; 197(4):361-7. PubMed ID: 9873175
    [Abstract] [Full Text] [Related]

  • 3. [In vitro antifungal activity of ravuconazole against isolates of dermatophytes and Candida species from patients with dermatomycoses].
    Yamaguchi H, Ikeda F, Iyoda T, Suzuki M, Mikawa T.
    Med Mycol J; 2014 Jan; 55(4):J157-63. PubMed ID: 25742996
    [Abstract] [Full Text] [Related]

  • 4. Antifungal susceptibilities of dermatophytic agents isolated from clinical specimens.
    Cetinkaya Z, Kiraz N, Karaca S, Kulac M, Ciftci IH, Aktepe OC, Altindis M, Kiyildi N, Piyade M.
    Eur J Dermatol; 2005 Jan; 15(4):258-61. PubMed ID: 16048753
    [Abstract] [Full Text] [Related]

  • 5. Identification and antifungal susceptibility of fungi isolated from dermatomycoses.
    Silva LB, de Oliveira DB, da Silva BV, de Souza RA, da Silva PR, Ferreira-Paim K, Andrade-Silva LE, Silva-Vergara ML, Andrade AA.
    J Eur Acad Dermatol Venereol; 2014 May; 28(5):633-40. PubMed ID: 23556501
    [Abstract] [Full Text] [Related]

  • 6. Clinical and Laboratory Features of Six Cases of Candida and Dermatophyte Folliculitis and a Review of Published Studies.
    Durdu M, Güran M, Kandemir H, Ilkit M, Seyedmousavi S.
    Mycopathologia; 2016 Feb; 181(1-2):97-105. PubMed ID: 26337525
    [Abstract] [Full Text] [Related]

  • 7. Molecular characterization and antifungal susceptibility profile of dermatophytes isolated from scalp dermatophyte carriage in primary school children in Arak city, Center of Iran.
    Allahdadi M, Hajihossein R, Kord M, Rahmati E, Amanloo S, Didehdar M.
    J Mycol Med; 2019 Apr; 29(1):19-23. PubMed ID: 30660447
    [Abstract] [Full Text] [Related]

  • 8. Molecular Characterization and In Vitro Antifungal Susceptibility of 316 Clinical Isolates of Dermatophytes in Iran.
    Ansari S, Hedayati MT, Zomorodian K, Pakshir K, Badali H, Rafiei A, Ravandeh M, Seyedmousavi S.
    Mycopathologia; 2016 Feb; 181(1-2):89-95. PubMed ID: 26369643
    [Abstract] [Full Text] [Related]

  • 9. Species distribution and antifungal susceptibilities of dermatophytes during a one year period at a university hospital in Turkey.
    Ozkutuk A, Ergon C, Yulug N.
    Mycoses; 2007 Mar; 50(2):125-9. PubMed ID: 17305776
    [Abstract] [Full Text] [Related]

  • 10. MIC and Upper Limit of Wild-Type Distribution for 13 Antifungal Agents against a Trichophyton mentagrophytes-Trichophyton interdigitale Complex of Indian Origin.
    Shaw D, Singh S, Dogra S, Jayaraman J, Bhat R, Panda S, Chakrabarti A, Anjum N, Chowdappa A, Nagamoti M, Varshney U, Vanam HP, Savio J, Antony M, Rudramurthy SM.
    Antimicrob Agents Chemother; 2020 Mar 24; 64(4):. PubMed ID: 32015042
    [Abstract] [Full Text] [Related]

  • 11. Susceptibility of dermatophyte isolates obtained from a large worldwide terbinafine tinea capitis clinical trial.
    Ghannoum MA, Wraith LA, Cai B, Nyirady J, Isham N.
    Br J Dermatol; 2008 Sep 24; 159(3):711-3. PubMed ID: 18510668
    [Abstract] [Full Text] [Related]

  • 12. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.
    Gupta AK, Kohli Y.
    Br J Dermatol; 2003 Aug 24; 149(2):296-305. PubMed ID: 12932235
    [Abstract] [Full Text] [Related]

  • 13. Prevalence and antifungal susceptibility patterns of dermatophytes isolated from patients with neoplastic diseases: a case control study.
    Irimie M, Oanta A, Irimie CA, Minea DI.
    Acta Dermatovenerol Croat; 2015 Aug 24; 23(2):108-13. PubMed ID: 26228822
    [Abstract] [Full Text] [Related]

  • 14. In vitro activities of antifungal drugs against dermatophytes isolated in Tokat, Turkey.
    Yenişehirli G, Tunçoğlu E, Yenişehirli A, Bulut Y.
    Int J Dermatol; 2013 Dec 24; 52(12):1557-60. PubMed ID: 24134487
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of antifungal agents against fungal spores: An in vitro study using microplate laser nephelometry and an artificially infected 3D skin model.
    Fink S, Burmester A, Hipler UC, Neumeister C, Götz MR, Wiegand C.
    Microbiologyopen; 2022 Feb 24; 11(1):e1257. PubMed ID: 35212482
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In vitro susceptibility of dermatomycoses agents to six antifungal drugs and evaluation by fractional inhibitory concentration index of combined effects of amorolfine and itraconazole in dermatophytes.
    Tamura T, Asahara M, Yamamoto M, Yamaura M, Matsumura M, Goto K, Rezaei-Matehkolaei A, Mirhendi H, Makimura M, Makimura K.
    Microbiol Immunol; 2014 Jan 24; 58(1):1-8. PubMed ID: 24215461
    [Abstract] [Full Text] [Related]

  • 19. A study of dermatophytes and their in-vitro antifungal sensitivity.
    Sumana MN, Rajagopal V.
    Indian J Pathol Microbiol; 2002 Apr 24; 45(2):169-72. PubMed ID: 12696733
    [Abstract] [Full Text] [Related]

  • 20. In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
    Bueno JG, Martinez C, Zapata B, Sanclemente G, Gallego M, Mesa AC.
    Clin Exp Dermatol; 2010 Aug 24; 35(6):658-63. PubMed ID: 19874354
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.